Skip to main content

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans, LA.  

A live webcast will be available to registered participants. Following the presentation, the webcast replay will be available at https://event.summitcast.com/view/d69xRqMspwymhwGUDdQoes/JC9qqvWhWggYawxGnDNtmz

About Carlsmed, Inc.

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Investor Relations
Caroline Corner, PhD
IR@Carlsmed.com 

Media
LeAnn Burton
Senior Director Brand Marketing
LBurton@Carlsmed.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.83
-1.17 (-0.56%)
AAPL  265.64
+1.46 (0.55%)
AMD  197.02
-3.19 (-1.59%)
BAC  50.27
+0.44 (0.88%)
GOOG  307.24
-4.19 (-1.35%)
META  657.67
+9.49 (1.46%)
MSFT  399.63
+6.89 (1.76%)
NVDA  182.72
+5.53 (3.12%)
ORCL  147.71
+2.31 (1.59%)
TSLA  403.83
+1.32 (0.33%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.